Previous close | 62.97 |
Open | 63.17 |
Bid | 62.07 x 0 |
Ask | 63.18 x 0 |
Day's range | 62.62 - 63.26 |
52-week range | 59.18 - 73.66 |
Volume | |
Avg. volume | 6 |
Market cap | 31.47B |
Beta (5Y monthly) | 1.05 |
PE ratio (TTM) | 16.22 |
EPS (TTM) | 3.86 |
Earnings date | 31 Jul 2024 - 05 Aug 2024 |
Forward dividend & yield | 1.11 (1.77%) |
Ex-dividend date | 17 May 2024 |
1y target est | N/A |
Cognizant (CTSH) introduces Neuro Edge. The suite empowers businesses with real-time, secure AI at the edge for faster decisions and operational efficiency across industries.
Cognizant (NASDAQ: CTSH) announced the launch of Cognizant Neuro®️ Edge, a new platform in the Cognizant Neuro®️ suite, designed to empower businesses across industries to leverage artificial intelligence and generative AI at the edge.
With its stock down 5.2% over the past three months, it is easy to disregard Cognizant Technology Solutions...